Portland, OR (PRWEB) December 13, 2006
Innovation Asset Group, a leading provider of web-based enterprise applications for improving the management of intellectual assets & contracts, is seeing notable adoption of its flagship product, Decipher™ by companies in the life sciences industries. Decipher empowers biotechnology, pharmaceutical and medical device companies to maximize the value of their intellectual assets including patents, trademarks, R&D, copyrights, and related commitments.
LI-COR Biosciences, a leading biotechnology instrumentation company, selected Decipher after a detailed and careful evaluation. "We chose Decipher to systematically track and manage our licensing and business agreements," said Brad Roth, Ph.D., Licensing and Intellectual Property Manager at LI-COR. "Decipher is so flexible that we could configure it to fit our business needs. But the ultimate value of Decipher is that it helps us to diligently fulfill our contractual responsibilities as well as tracking the obligations of our business partners."
Success in life science industries is critically dependent upon a company's ability to leverage, extract, manage and assess the value of all their intellectual property. "The cornerstone of a life science company is its intellectual property… a strong IP strategy leads to higher returns for venture capitalists and so they look for companies that have a solid IP strategy focused on building a high value IP portfolio, and that can leverage those IP assets effectively into new revenue streams and markets," noted N. Mitchell (2006) in The Importance of Intellectual Property in Life Science Ventures and How It Impacts Capital Raising.
"We are seeing a surge of interest in Decipher to help corporations more methodically manage IP, licensing and other agreements, particularly from IP-intensive industry sectors such as life sciences," said Shawn Pilkington, VP of Business Development at Innovation Asset. "We provide an enterprise application suite that allows these companies to maximize the value of their IP while managing the real risks associated with compliance and disclosure."
Decipher is available to enterprises either as an on-demand solution hosted by Innovation Asset or installed on internal company servers.
About Innovation Asset Group
Innovation Asset empowers companies to reveal hidden value by optimizing their intellectual assets, key contracts and commitments. Founded in 2002, the core team consists of experts in law, IP valuation, finance, and technology. Few companies have effective systems in place to maximize the commercial potential of their patents, trademarks, copyrights, and trade secrets and control their contracts and agreements. Innovation Asset was formed to address this problem. The company's flagship product, Decipher, is a web-based application suite for managing IP and contracts with advanced visualization, tracking, monitoring, and security capabilities. For the latest news and information about the company, visit http://www.innovation-asset.com.
Decipher is a trademark of Innovation Asset Group, Inc. All other trademarks are property of their respective owners. © 2006 Innovation Asset Group, Inc. All rights reserved
Media and Analyst Contact:
Shayla B. Sharp
Innovation Asset Group, Inc.